I M Poynten
Overview
Explore the profile of I M Poynten including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Farrell R, Zaunders J, Poynten I, Anderson L, Evans L
Gynecol Oncol Rep
. 2024 Mar;
52:101350.
PMID: 38445009
This is the first report describing detailed T cell responses to viral-like proteins contained in an HPV specific vaccine given in combination with Imiquimod for treatment of persistent VAIN2/3. We...
2.
Templeton D, Williamson C, Jin F, Hillman R, Roberts J, Law C, et al.
Cancer Epidemiol
. 2020 Jan;
64:101661.
PMID: 31918181
Objectives: To investigate factors associated with larger burden of intra-anal high-grade squamous intraepithelial lesions (HSIL) in a natural history study of HSIL. Methods: 617 gay and bisexual men (GBM) attended...
3.
Goddard S, Templeton D, Petoumenos K, Jin F, Hillman R, Law C, et al.
Cancer Epidemiol
. 2018 Nov;
58:12-16.
PMID: 30439602
Background: The association between anal high-grade squamous intraepithelial lesion (HSIL) and anal symptoms has not been systematically investigated. Methods: The Study of Prevention of Anal Cancer is a prospective cohort...
4.
Vaccher S, Grulich A, McAllister J, Templeton D, Bloch M, McNulty A, et al.
BMJ Open
. 2016 Jun;
6(6):e012179.
PMID: 27324719
Introduction: Despite a number of HIV prevention strategies, the number of new HIV infections remains high. In Australia, over three-quarters of new HIV diagnoses are in gay and bisexual men...
5.
Moore C, Grulich A, Prestage G, Gidding H, Jin F, Mao L, et al.
HIV Med
. 2015 Sep;
17(5):327-39.
PMID: 26344061
Objectives: There is evidence that HIV-positive patients are suffering from a greater burden of morbidity as they age due to nonAIDS-related complications. To date it has been difficult to determine...
6.
Jamani S, Gulholm T, Poynten I, Templeton D
Sex Transm Infect
. 2013 May;
89(7):604-6.
PMID: 23698512
Objectives: Australian HIV postexposure prophylaxis (PEP) guidelines recommend Chlamydia trachomatis (CT) and Neisseria gonorrheae (NG) testing at both baseline and 2-week postexposure visits. We aimed to determine the diagnostic yield...
7.
Poynten I, Jin F, Prestage G, Kaldor J, Kippax S, Grulich A
HIV Med
. 2010 May;
11(10):635-41.
PMID: 20456511
Objectives: The aim of the study was to assess whether subpopulations with sufficiently high HIV incidences for HIV prevention trials can be identified in low HIV incidence settings such as...
8.
Poynten I, Jin F, Prestage G, Kaldor J, Imrie J, Grulich A
HIV Med
. 2009 Dec;
11(4):282-8.
PMID: 20015220
Objectives: The aim of the study was to explore the awareness of rectal microbicides, the use of pre-exposure prophylaxis (PREP) and the willingness to participate in biomedical HIV prevention trials...
9.
Guinot D, Ho M, Poynten I, McAllister J, Pierce A, Pell C, et al.
HIV Med
. 2009 Feb;
10(4):199-208.
PMID: 19207598
Objective: The aim of the study was to determine the cost-effectiveness of HIV nonoccupational post-exposure prophylaxis (NPEP) in Australia. Methods: A retrospective cost analysis of a population-based observational cohort of...
10.
Poynten I, Smith D, Cooper D, Kaldor J, Grulich A
HIV Med
. 2007 Jul;
8(6):374-81.
PMID: 17661845
Objective: The aim of the study was to describe the use of nonoccupational postexposure prophylaxis (NPEP) in Australia, and to estimate the number of HIV infections that its use prevented....